A new meta-analysis finds no clear long-term cardiovascular benefit from beta-blockers after myocardial infarction in ...
Beta-thalassemia, also called Cooley’s Anemia, is a blood disease that effects thousands of Americans. In a major step toward a curative therapy, rare disease drug development firm Errant Gene ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
The management of hypertension has historically been shaped by two competing schools of thought. The first posits that reducing blood pressure itself is the ultimate priority, with clinical benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback